BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 21704889)

  • 21. Effect of allergen-specific immunotherapy on plasma level of platelet factor 4 (PF-4) and beta-thromboglobulin (beta-TG), platelet activation markers in patients with house dust mite allergy.
    Kasperska-Zajac A; Brzoza Z; Rogala B
    Vaccine; 2007 May; 25(18):3595-8. PubMed ID: 17291641
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of high-dose sublingual immunotherapy in children allergic to house dust mites in real-life clinical practice.
    Ferrés J; Justicia JL; García MP; Muñoz-Tudurí M; Alvà V
    Allergol Immunopathol (Madr); 2011; 39(3):122-7. PubMed ID: 20570032
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sublingual-oral administration of standardized allergenic extracts: phase 1 safety and dosing results.
    Esch RE; Bush RK; Peden D; Lockey RF
    Ann Allergy Asthma Immunol; 2008 May; 100(5):475-81. PubMed ID: 18517081
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The impact of subcutaneous immunotherapy with Dermatophagoides farinae and Dermatophagoides pteronyssinus on the quality of life of patients with allergic rhinitis and asthma].
    Yepes-Núñez JJ; Gómez C; Espinoza Y; Cardona R
    Biomedica; 2014; 34(2):282-90. PubMed ID: 24967933
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the long-term efficacy of subcutaneous and sublingual immunotherapies in perennial rhinitis.
    Tahamiler R; Saritzali G; Canakcioglu S; Ozcora E; Dirican A
    ORL J Otorhinolaryngol Relat Spec; 2008; 70(3):144-50. PubMed ID: 18391573
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aqueous intradermal low-dose house dust mite immunotherapy in tropical settings: a valid cost-effective approach for developing nations?
    Rondon C; Sánchez-Borges M; Cupello ER; Fabiano F; Capriles-Hulett A
    Allergol Immunopathol (Madr); 2021; 49(2):31-39. PubMed ID: 33641291
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The efficacy and safety of two commercial house dust mite extracts for allergic rhinitis: a head-to-head study.
    Li J; Wu Y; Yang Y; Huang N; Li W; Zhang S; Jiang Q; Yang L; Zhu R
    Int Forum Allergy Rhinol; 2019 Aug; 9(8):876-882. PubMed ID: 31322838
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in serum specific IgG4 and IgG4/ IgE ratio in mite-sensitized Taiwanese children with allergic rhinitis receiving short-term sublingual-swallow immunotherapy: a multicenter, randomized, placebo-controlled trial.
    Tseng SH; Fu LS; Nong BR; Weng JD; Shyur SD
    Asian Pac J Allergy Immunol; 2008; 26(2-3):105-12. PubMed ID: 19054928
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and safety of a once-daily sublingual immunotherapy without escalation regimen in house dust mite-induced allergic rhinitis.
    Mun SJ; Shin JM; Han DH; Kim JW; Kim DY; Lee CH; Min YG; Rhee CS
    Int Forum Allergy Rhinol; 2013 Mar; 3(3):177-83. PubMed ID: 23044892
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [House dust mite allergy].
    Carrard A; Pichler C
    Ther Umsch; 2012 Apr; 69(4):249-52. PubMed ID: 22477664
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of sublingual specific immunotherapy in intermittent and persistent allergic rhinitis in children: an observational case-control study on 171 patients. The EFESO-children multicenter trial.
    Acquistapace F; Agostinis F; Castella V; Kantar A; Novembre E; Perrone MR; Pietrasanta M; Sambugaro R; Milani M
    Pediatr Allergy Immunol; 2009 Nov; 20(7):660-4. PubMed ID: 19320852
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sublingual immunotherapy to house dust mite in pediatric patients with allergic rhinitis and asthma: a retrospective analysis of clinical course over a 3-year follow-up period.
    Nuhoglu Y; Ozumut SS; Ozdemir C; Ozdemir M; Nuhoglu C; Erguven M
    J Investig Allergol Clin Immunol; 2007; 17(6):375-8. PubMed ID: 18088019
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Observational study of the safety of an ultra-rush sublingual immunotherapy regimen to treat rhinitis due to house dust mites.
    Roger A; Justicia JL; Navarro LÁ; Eseverri JL; Ferrès J; Malet A; Alvà V
    Int Arch Allergy Immunol; 2011; 154(1):69-75. PubMed ID: 20664280
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical efficacy and immunological mechanisms of sublingual and subcutaneous immunotherapy in asthmatic/rhinitis children sensitized to house dust mite: an open randomized controlled trial.
    Eifan AO; Akkoc T; Yildiz A; Keles S; Ozdemir C; Bahceciler NN; Barlan IB
    Clin Exp Allergy; 2010 Jun; 40(6):922-32. PubMed ID: 20100188
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The efficacy of sublingual immunotherapy for house dust mites respiratory allergy: results of a GA2LEN meta-analysis.
    Compalati E; Passalacqua G; Bonini M; Canonica GW
    Allergy; 2009 Nov; 64(11):1570-9. PubMed ID: 19796205
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Efficacy evaluation of specific immunotherapy with standardized dermatophagoides pteronyssinus extract for allergic rhinitis accompanied with asthma].
    Chen J; Kong W; Xiang J; Shu H; Shi Q; Tan H; Lu Z; Zhou Y; Zhang X
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2010 Jan; 24(2):57-9. PubMed ID: 20306851
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical and immunologic effects of sublingual immunotherapy in asthmatic children sensitized to mites: a double-blind, randomized, placebo-controlled study.
    Lue KH; Lin YH; Sun HL; Lu KH; Hsieh JC; Chou MC
    Pediatr Allergy Immunol; 2006 Sep; 17(6):408-15. PubMed ID: 16925685
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term efficacy of standardised specific subcutaneous immunotherapy in children with persistent allergic rhinitis due to multiple allergens including house dust mites.
    Song Y; Long J; Wang T; Xie J; Wang M; Tan G
    J Laryngol Otol; 2018 Mar; 132(3):230-235. PubMed ID: 29374499
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of sublingual immunotherapy with high-dose mite extracts in asthma: a multi-center, double-blind, randomized, and placebo-controlled study in Taiwan.
    Niu CK; Chen WY; Huang JL; Lue KH; Wang JY
    Respir Med; 2006 Aug; 100(8):1374-83. PubMed ID: 16403616
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Rush immunotherapy of perennial allergic rhinitis].
    Ito K
    Arerugi; 1989 Nov; 38(11):1246-54. PubMed ID: 2627159
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.